Luke 8:2

Context
8:2 and also some women¹ who had been healed of evil spirits and disabilities:² Mary³ (called Magdalene), from whom seven demons had gone out,

Luke 23:49

Context
23:49 And all those who knew Jesus⁴ stood at a distance, and the women who had followed him from Galilee saw⁵ these things.

Luke 23:55

Context
23:55 The⁶ women who had accompanied Jesus⁷ from Galilee followed, and they saw the tomb and how his body was laid in it.

Luke 24:24

Context
24:24 Then⁸ some of those who were with us went to the tomb, and found it just as the women had said, but they did not see him.”⁹

[8:2] ¹sn There is an important respect shown to women in this text, as their contributions were often ignored in ancient society.

[8:2] ²tn Or “illnesses.” The term ἀσθένεια (asqeneia) refers to the state of being ill and thus incapacitated in some way – “illness, disability, weakness.” (L&N 23.143).

[8:2] ³sn This Mary is not the woman mentioned in the previous passage (as some church fathers claimed), because she is introduced as a new figure here. In addition, she is further specified by Luke with the notation called Magdalene, which seems to distinguish her from the woman at Simon the Pharisee’s house.

[23:49] ⁴tn Grk “him”; the referent (Jesus) has been specified in the translation for clarity.

[23:49] ⁵tn Technically the participle ὁρῶσαι (Jorwsai) modifies only γυναῖκες (gunaike") since both are feminine plural nominative, although many modern translations refer this as well to the group of those who knew Jesus mentioned in the first part of the verse. These events had a wide array of witnesses.

[23:55] ⁷tn Here δέ (de) has not been translated.

[23:55] ⁸tn Grk “him”; the referent (Jesus) has been specified in the translation for clarity.

[24:24] ¹⁰tn Here καί (kai) has been translated as “then” to indicate the implied sequence of events within the narrative.

[24:24] ¹¹tn Here the pronoun αὐτόν (auton), referring to Jesus, is in an emphatic position. The one thing they lacked was solid evidence that he was alive.